Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pascal Le Priol"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 45:1688-1692
We compared the oral antibacterial activities of telithromycin (HMR 3647), a new ketolide drug, in different infections induced in mice by Staphylococcus aureus, Streptococcus pneumoniae , streptococci, enterococci, and Haemophilus influenzae with th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d5c835a022c13fd018512aaed305251
https://doi.org/10.1128/aac.45.6.1688-1692.2001
https://doi.org/10.1128/aac.45.6.1688-1692.2001
Publikováno v:
The Journal of antimicrobial chemotherapy. 48(1)
The in vitro activity of HMR 3562, a new 2-fluoro-ketolide drug, was investigated against 95 enterococci, including 36 vancomycin-resistant strains. HMR 3562 inhibited 90% of enterococci susceptible or resistant to erythromycin A at 0.005 and 0.6 mg/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cd3b4521ea6630b91d249968754a19a
https://pubmed.ncbi.nlm.nih.gov/11418524
https://pubmed.ncbi.nlm.nih.gov/11418524
Autor:
Pascal Le Priol, Alain Bonnefoy
Publikováno v:
The Journal of antimicrobial chemotherapy. 47(4)
Telithromycin (HMR 3647) is a ketolide suitable for the treatment of respiratory infections. The aim of this study was to demonstrate its antibacterial efficacy against an erythromycin-susceptible Staphylococcus aureus, an erythromycin-resistant Stre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef532fcfa2376aeb3cc6782d70ddf838
https://pubmed.ncbi.nlm.nih.gov/11266424
https://pubmed.ncbi.nlm.nih.gov/11266424